Horizon is a biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.
Horizon's global headquarters is in Dublin, Ireland and its U.S. headquarters is in Deerfield, Ill. The Company also has offices in Chicago, Ill.; South San Francisco, Calif.; Washington, D.C.; Gaithersburg, Md.; Rockville, Md.; Mannheim, Germany and a growing presence in Japan.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Aug 4, 2021 at 8:00 AM EDT
Horizon Therapeutics Second Quarter 2021 Earnings Call
Jun 22, 2021 at 10:00 AM EDT
BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology
Jun 3, 2021 at 1:00 PM EDT
Jefferies Virtual Health Care Conference
May 11, 2021 at 3:30 PM EDT
Bank of America Securities 2021 Health Care Conference (Virtual)
May 5, 2021 at 8:00 AM EDT
Horizon Therapeutics First Quarter 2021 Earnings Call